Explore our ACCC 2020 Impact Report, the Oncology Issues, Vol.36, N.3, and our video podcast, CANCER BUZZ TV.



In This Section

Home / Learn / Cancer Types / Hematologic Malignancies

Hematologic Malignancies

Blood/hematologic cancers most often begin in the bone marrow where blood is produced. Stem cells in the bone marrow develop into white blood cells, red blood cells, or platelets. Blood cancers occur when uncontrolled growth of abnormal blood cells overtakes the development of normal blood cells and interferes with the regular functions of these cells. Blood cancers fall into three categories: leukemia, lymphoma, and myeloma.

Developing quality improvement programs that aim to reduce disparities and improve the standard of care received by patients with blood/hematologic cancers are a key priority in ACCC’s educational portfolio. Leverage our recent research and explore practical, actionable resources to implement in your cancer program or practice today.

Video Podcast


On-Demand Webinars

Featured Programs

Returning to Practice in the Post-COVID-19 Era: Hematology Disease Education

This education project will help cancer programs and practices transition from pre- to post-pandemic response by showcasing the solutions that have worked for practices that have successfully adapted their services to the restrictions imposed by COVID-19. 
Learn More

Returning to Practice in the Post-COVID-19 Era: Resources for Treating Chronic Lymphocytic Leukemia

To help cancer practices prepare for an expected increase in undiagnosed patients and a surge in upstaged patients, this project aims to teach care team members short- and long-term solutions to operational challenges as the pandemic recedes, paying special attention to traditionally underserved patient populations.
Learn More

MRD Clinical Updates in Chronic Lymphocytic Leukemia

Join expert faculty in the field of hematologic malignancies and gain important and practical information for the assessment of measurable residual disease (MRD) as part of routine clinical practice for their patients with chronic lymphocytic leukemia (CLL).

The presentation will be valuable for understanding the impact of MRD on treatment decisions and practice patterns, which has promise to lead to major improvements in outcomes for CLL patients in the very near future.
Learn More

Advances in Multiple Myeloma and Acute Lymphoblastic Leukemia ECHO Clinic

ACCC is committed to help ensure access to recommended care for patients who receive treatment for multiple myeloma or acute lymphoblastic leukemia through a partnership with the American Cancer Society and Project ECHO. The educational focus will be on bringing the latest content knowledge and best practices in the treatment of these hematological cancer patients to your cancer care team.

Participation in the TeleECHO Clinic is free. The clinics will convene by videoconference each month.
Learn More

Integration of MRD Testing: A Pathway for Patients with B-Cell Acute Lymphoblastic Leukemia

B-cell Acute Lymphoblastic Leukemia (ALL) was the first disease state with an FDA-approved treatment for MRD. This project will help lay the foundation for MRD testing in patients with B-cell ALL to create better-informed multidisciplinary cancer care teams. Ultimately, this work will showcase not only the importance of MRD testing, but also how it can be best integrated into the cancer care workflow. 
Learn More

Multidisciplinary Acute Lymphocytic Leukemia Care

The ACCC Multidisciplinary Acute Lymphocytic Leukemia (ALL) Care education project seeks to identify key barriers to and opportunities for improvement in the cancer care team’s support of patients diagnosed with ALL, including utilization of MRD testing, detection, and monitoring.

Read ACCC’s environmental scan including an overview of the current landscape for ALL diagnosis and treatment, along with opportunities to improve patient care.
Learn More

Multidisciplinary Chronic Lymphocytic Leukemia Care

The ACCC Multidisciplinary Chronic Lymphocytic Leukemia (CLL) Care education project seeks to understand the current landscape of treating CLL in the community, identify effective practices and potential gaps in provider and patient communication, and provide peer-to-peer learning and resources for increased awareness and best practices in multidisciplinary care for patients with CLL.
Learn More

Multidisciplinary Multiple Myeloma Care

Guided by an expert Advisory Committee, this ACCC education project provides support to multidisciplinary cancer care teams in diagnosing, testing, and treating patients with multiple myeloma. This project serves to:

  • Raise awareness about provider education needs related to this patient population
  • Provide vetted, designated resources for unmet education needs
  • Establish a network of multidisciplinary team members with interest and expertise in caring for patient with multiple myeloma

Learn More

Transplant Treatment Path

The ACCC education project, The Transplant Treatment Path: Optimizing Patient-Centered Care for ASCT in Multiple Myeloma, explores steps for improving provider communication to optimize the treatment of multiple myeloma patients in the community cancer center pre- and post-autologous stem cell transplant (ASCT).
Learn More
Sources: American Cancer Society; American Society of Hematology; Leukemia & Lymphoma Society; National Cancer Institute.